These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 36544633)

  • 1. Identification of the molecular mechanism and candidate markers for diabetic nephropathy.
    Chen C; Liu L; Luo J
    Ann Transl Med; 2022 Nov; 10(22):1248. PubMed ID: 36544633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key biomarkers in diabetic nephropathy via bioinformatic analysis.
    Zeng M; Liu J; Yang W; Zhang S; Liu F; Dong Z; Peng Y; Sun L; Xiao L
    J Cell Biochem; 2019 May; 120(5):8676-8688. PubMed ID: 30485525
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
    Gholaminejad A; Fathalipour M; Roointan A
    BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of PDK4 as Hub Gene for Diabetic Nephropathy Using Co-Expression Network Analysis.
    Han Y; Jin L; Wang L; Wei L; Tu C
    Kidney Blood Press Res; 2023; 48(1):522-534. PubMed ID: 37385224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Identification of Differentially Expressed Genes Between Diabetic Nephropathy Glomerular and Normal Glomerular via Bioinformatics Technology.
    Du J; Yang J; Meng L
    Comb Chem High Throughput Screen; 2021; 24(5):645-655. PubMed ID: 32954999
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
    Guo M; Dai Y; Jiang L; Gao J
    Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Screening of the Key Genes and Signalling Pathways for Diabetic Nephropathy Using Bioinformatics Analysis.
    Li Z; Feng J; Zhong J; Lu M; Gao X; Zhang Y
    Front Endocrinol (Lausanne); 2022; 13():864407. PubMed ID: 35923621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dysregulation and imbalance of innate and adaptive immunity are involved in the cardiomyopathy progression.
    He B; Quan LP; Cai CY; Yu DY; Yan W; Wei QJ; Zhang Z; Huang XN; Liu L
    Front Cardiovasc Med; 2022; 9():973279. PubMed ID: 36148059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioinformatics analysis identifies diagnostic biomarkers and their correlation with immune infiltration in diabetic nephropathy.
    Huang M; Zhu Z; Nong C; Liang Z; Ma J; Li G
    Ann Transl Med; 2022 Jun; 10(12):669. PubMed ID: 35845512
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
    Cao H; Rao X; Jia J; Yan T; Li D
    Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Lumican and Fibromodulin as Hub Genes Associated with Accumulation of Extracellular Matrix in Diabetic Nephropathy.
    Feng S; Gao Y; Yin D; Lv L; Wen Y; Li Z; Wang B; Wu M; Liu B
    Kidney Blood Press Res; 2021; 46(3):275-285. PubMed ID: 33887734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the shared molecular mechanism of microvascular and macrovascular complications in diabetes: Seeking the hub of circulatory system injury.
    Yuchen C; Hejia Z; Fanke M; Qixin D; Liyang C; Xi G; Yanxia C; Xiongyi Y; Zhuohang X; Guoguo Y; Min F
    Front Endocrinol (Lausanne); 2023; 14():1032015. PubMed ID: 36755923
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HEMGN and SLC2A1 might be potential diagnostic biomarkers of steroid-induced osteonecrosis of femoral head: study based on WGCNA and DEGs screening.
    Wu Z; Wen Y; Fan G; He H; Zhou S; Chen L
    BMC Musculoskelet Disord; 2021 Jan; 22(1):85. PubMed ID: 33451334
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nine hub genes as the potential indicator for the clinical outcome of diabetic nephropathy.
    Song X; Gong M; Chen Y; Liu H; Zhang J
    J Cell Physiol; 2019 Feb; 234(2):1461-1468. PubMed ID: 30078220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Hub Genes and Potential ceRNA Networks of Diabetic Nephropathy by Weighted Gene Co-Expression Network Analysis.
    Li G; Zhang J; Liu D; Wei Q; Wang H; Lv Y; Ye Z; Liu G; Li L
    Front Genet; 2021; 12():767654. PubMed ID: 34790229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of Effective Diagnostic Biomarkers and Immune Cell Infiltration in Atopic Dermatitis by Comprehensive Bioinformatics Analysis.
    Li C; Lu Y; Han X
    Front Mol Biosci; 2022; 9():917077. PubMed ID: 35911963
    [No Abstract]   [Full Text] [Related]  

  • 17. Identification and validation of voltage-dependent anion channel 1-related genes and immune cell infiltration in diabetic nephropathy.
    Lin J; Weng M; Zheng J; Nie K; Rao S; Zhuo Y; Wan J
    J Diabetes Investig; 2024 Jan; 15(1):87-105. PubMed ID: 37737517
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Revealing the underlying mechanism of diabetic nephropathy viewed by microarray analysis.
    Qu W; Han C; Li M; Zhang J; Li L
    Exp Clin Endocrinol Diabetes; 2015 Jun; 123(6):353-9. PubMed ID: 25918880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Ribonuclease 6 as an immunoinflammatory key gene associated with the glomerular injury in diabetic nephropathy.
    Li T; Wang Y; Zhu C; Yang Y; Long C; Chen Q
    Sci Rep; 2022 Nov; 12(1):19709. PubMed ID: 36385487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of hub genes in diabetic kidney disease via multiple-microarray analysis.
    Zhang Y; Li W; Zhou Y
    Ann Transl Med; 2020 Aug; 8(16):997. PubMed ID: 32953797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.